LM Mir
Impact in
- Biotechnology top 0.5%
- Microbial Inactivation Methods
- Transgenic Plants and Applications
- Immunology top 10%
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Microbial Inactivation Methods 8
- Transgenic Plants and Applications 2
- Cancer Research and Treatments 1
-
- Toxin Mechanisms and Immunotoxins 4
- Co-authors
- Stéphane Orlowski (7 shared papers)Bruno Poddevin (2 shared papers)C. Domenge (2 shared papers)Jean Belehradek (3 shared papers)Claude Paoletti (2 shared papers)B Luboïnski (1 shared paper)G Schwaab (1 shared paper)Reintgen Ds (1 shared paper)
- Journals
- British Journal of Cancer (3 papers)médecine/sciences (1 paper)PubMed (5 papers)
- Partner nations
- FranceUnited States
In The Last Decade
LM Mir
9 papers receiving 798 citations
Peers
Comparison fields: 5 of 49
- Biotechnology 789
- Immunology 324
- Physiology 69
- Biomedical Engineering 521
- Biophysics 18
Countries citing papers authored by LM Mir
This map shows the geographic impact of LM Mir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LM Mir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LM Mir more than expected).
Fields of papers citing papers by LM Mir
This network shows the impact of papers produced by LM Mir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LM Mir. The network helps show where LM Mir may publish in the future.
Co-authors
The 25 scholars most cited alongside LM Mir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 356 | |
| 2 | [Electrochemotherapy, a new antitumor treatment: first clinical trial]. | 1991 | 207 |
| 3 | 1998 | 96 | |
| 4 | Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. | 1992 | 87 |
| 5 | 1997 | 82 | |
| 6 | [Potentiation of the antitumoral effect of electrochemotherapy by immunotherapy with allogeneic cells producing interleukin 2]. | 1992 | 14 |
| 7 | [Antitumor electro-chemotherapy]. | 1994 | 9 |
| 8 | [Inhibition of the tumoral growth induced by the injection of histo-incompatible cells producing interleukin-2]. | 1992 | 1 |
| 9 | 1998 | 1 |
About LM Mir
LM Mir is a scholar working on Biotechnology, Immunology, Biomedical Engineering, Organic Chemistry and Molecular Biology, having authored 9 papers that have together received 853 indexed citations. Recurring topics across this work include Microbial Inactivation Methods (8 papers), Toxin Mechanisms and Immunotoxins (4 papers), Microfluidic and Bio-sensing Technologies (2 papers), Transgenic Plants and Applications (2 papers), Microwave-Assisted Synthesis and Applications (1 paper), Cancer Research and Treatments (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Biotechnology (789 citations), Immunology (324 citations), Physiology (69 citations), Biomedical Engineering (521 citations) and Biophysics (18 citations). LM Mir has collaborated with scholars based in France and United States. Frequent co-authors include Stéphane Orlowski, Bruno Poddevin, C. Domenge, Jean Belehradek, Claude Paoletti, B Luboïnski, G Schwaab, Reintgen Ds, Marie‐Pierre Rols and R. A. Gilbert. Their work appears in journals such as British Journal of Cancer, médecine/sciences and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.